While drug discovery was an early target for AI capabilities, the technology’s predictive powers have made it a good fit for many other facets of the industry. As pharma leverages real-world uses of AI, the industry has also been careful about big-picture hype for the technology as some of its limitations become clear. INCLUDED IN THIS TRENDLINE The FDA was all in on AI. Will that change? Where pharma leaders say AI hasn’t delivered How well are AI-discovered drugs faring in the clinic?
